Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitrous Oxide in Impulsive Aggression
NCT06118567Phase 2Recruiting
- Sponsor
- The Ohio State University
- Start
- Sep 2022
- Primary completion
- Aug 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of nitrous oxide in intermittent explosive disorder (IED), sponsored by The Ohio State University. Primary endpoints: Cortico-Limbic Response to Anger Faces at 24 hours and Brain Connectivity at 24 hours. Started Sep 2022; status: recruiting.
02
Drugs
nitrous oxide
03
Conditions
intermittent explosive disorder (IED)
Beyond the preview
Go deeper on NCT06118567.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06118567.